Aspen Pharmacare (OTCMKTS:APNHY) Reaches New 1-Year Low – Should You Sell?

Aspen Pharmacare Holdings Limited (OTCMKTS:APNHYGet Free Report) shares reached a new 52-week low on Tuesday . The stock traded as low as $8.26 and last traded at $8.26, with a volume of 276 shares trading hands. The stock had previously closed at $9.38.

Aspen Pharmacare Stock Down 11.9 %

The company has a debt-to-equity ratio of 0.30, a current ratio of 1.81 and a quick ratio of 1.07. The stock’s 50 day simple moving average is $9.66 and its two-hundred day simple moving average is $11.25.

Aspen Pharmacare Company Profile

(Get Free Report)

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.

Read More

Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.